Shukra Pharmaceuticals has fixed 21 March 2025 as the record date to ascertain the eligibility of Shareholders for the purpose of sub-division / split of the Equity Shares of the comp-any such that every 1(one) Equity Share having nominal/face value of Rs. 10/- [Rupees Ten 0niyJ each be sub-divided into 10 [Ten) Equity shares having nominal/face value of Rs. 1/- (Rupees one 0nly) each.